Latest Breaking News On - Company intellectual property - Page 8 : vimarsana.com
. (“Allied” or the “Company”) (
OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce that it has successfully completed its first commercial shipment of cannabidiol (“CBD”) (containing less than 0.3% THC) from Colombia into the United States.
Allied has demonstrated its supply chain of producing in Colombia and exporting wholesale CBD products into international markets. This commercial US shipment was produced from seed in Colombia at Allied’s commercial production site, approved for export by the Colombian ministries of Justice, Health and Agriculture, transported to the United States, validated by the customs and border services of the United States of America and approved for entry to eventually arrive at the manufacturer of CBD products in the United States. A portion of this commercial CBD shipment will be used for retail ready CBD products. Allied’s supply chain goes from seed in Colombia to retail CBD product on the shelf in the United States, what we believe to be the largest market in the world.
ColombiaUnited-statesCanadaUnited-kingdomKelownaBritish-columbiaColombianAmericaBritishCalum-hughesPharma-development-ip-pd-strategyCompany-intellectual-propertyPressure BioSciences Awarded Three Additional Patents for Revolutionary Ultra Shear Technology Platform
ACCESSWIRE
14 May 2021, 00:19 GMT+10
Unique Commercial-Scale Capabilities for Highest-Quality Nanoemulsions of Oils in Water Enabled by PBI's UST Platform, Addressing Multiple Billion Dollar Opportunities in Diverse Markets Worldwide
SOUTH EASTON, MA / ACCESSWIRE / May 13, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ('PBI' or the 'Company'), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life sciences and other industries, today announced the award of three additional patents for its revolutionary Ultra Shear Technology™ (UST™) platform, all entitled 'System for High Pressure, High Shear Processing of Fluids'. The new patents, awarded in Japan (No. 6843063), Australia (No. 2016243553), and China (ZL201680026865.2), bring the Company's Intellectual Property ('IP') estate to a total of 6 issued patents for UST and 29 issued patents overall.
ChinaAustraliaJapanJohnb-hollisterRichardt-schumacherPressure-biosciences-incLinkedinTwitterOhio-state-universityCompany-intellectual-propertyUltra-shear-technologyConfirm
Unique Commercial-Scale Capabilities for Highest-Quality Nanoemulsions of Oils in Water Enabled by PBI's UST Platform, Addressing Multiple Billion Dollar Opportunities in Diverse Markets Worldwide
SOUTH EASTON, MA / ACCESSWIRE / May 13, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life sciences and other industries, today announced the award of three additional patents for its revolutionary Ultra Shear Technology (UST) platform, all entitled "System for High Pressure, High Shear Processing of Fluids". The new patents, awarded in Japan (No. 6843063), Australia (No. 2016243553), and China (ZL201680026865.2), bring the Company's Intellectual Property ("IP") estate to a total of 6 issued patents for UST and 29 issued patents overall.
ChinaAustraliaJapanJohnb-hollisterRichardt-schumacherPressure-biosciences-incLinkedinTwitterOhio-state-universityCompany-intellectual-propertyUltra-shear-technology